Patent ID: 8372815

Claim:
A method of suppressing or inhibiting conjunctivitis in a subject comprising the step of contacting said subject with a compound represented by the structure of the general formula (I) or (II), and/or a pharmaceutical salt or a pharmaceutical composition thereof: wherein R 1 is a linear, saturated, mono-unsaturated, or poly-unsaturated, alkyl chain ranging in length from 2 to 30 carbon atoms; R 2 is a linear, saturated, mono-unsaturated, or poly-unsaturated, alkyl chain ranging in length from 2 to 30 carbon atoms; Y is either nothing or a spacer group ranging in length from 2 to 30 atoms; X is a physiologically acceptable monomer, dimer, oligomer or polymer; and n is a number from 1 to 1000; wherein if Y is nothing, the phospholipid moiety is directly linked to X via an amide bond and if Y is a spacer, the spacer is directly linked to X via an amide or an esteric bond and to the phospholipid moiety via an amide bond.